Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,212,160
+$931,441 QoQ
Shares Held
36,472
+4.9% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#169
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $263,997,654 across 27 Diagnostics & Research names. LH ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
90,308 | $45,276,818 | |
| 2 | WAT |
Waters Corp /De/
|
87,450 | $32,797,248 | |
| 3 | DHR |
Danaher Corp /De/
|
170,806 | $32,535,126 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
25,355 | $32,391,266 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
42,922 | $22,731,061 | |
| 6 | DGX |
Quest Diagnostics Inc
|
95,054 | $20,146,695 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
35,025 | $18,438,561 | |
| 8 | LH |
Labcorp Holdings Inc.
This page
|
36,472 | $10,212,160 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,212,160 | 36,472 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,280,719 | 34,784 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,837,749 | 35,227 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,547,902 | 33,261 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $9,221,188 | 35,127 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $8,607,190 | 36,982 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,249,493 | 31,613 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,172,143 | 32,093 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,809,648 | 33,461 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||